FI66861C - Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan - Google Patents

Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan Download PDF

Info

Publication number
FI66861C
FI66861C FI790369A FI790369A FI66861C FI 66861 C FI66861 C FI 66861C FI 790369 A FI790369 A FI 790369A FI 790369 A FI790369 A FI 790369A FI 66861 C FI66861 C FI 66861C
Authority
FI
Finland
Prior art keywords
formula
propylendiaminer
disubstuffs
antihypertensiv
framstating
Prior art date
Application number
FI790369A
Other languages
English (en)
Finnish (fi)
Other versions
FI66861B (fi
FI790369A (fi
Inventor
Philippe Michel Jacque Manoury
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI790369A publication Critical patent/FI790369A/fi
Publication of FI66861B publication Critical patent/FI66861B/fi
Application granted granted Critical
Publication of FI66861C publication Critical patent/FI66861C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI790369A 1978-02-06 1979-02-05 Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan FI66861C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7803175A FR2421888A1 (fr) 1978-02-06 1978-02-06 Amides d'alkylene-diamines et leur application en therapeutique
FR7803175 1978-02-06
FR7836819 1978-12-29
FR7836819A FR2445323A2 (fr) 1978-02-06 1978-12-29 Amides d'alkylenediamines et leur application en therapeutique

Publications (3)

Publication Number Publication Date
FI790369A FI790369A (fi) 1979-08-07
FI66861B FI66861B (fi) 1984-08-31
FI66861C true FI66861C (fi) 1984-12-10

Family

ID=26220430

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790369A FI66861C (fi) 1978-02-06 1979-02-05 Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan

Country Status (23)

Country Link
US (1) US4315007A (xx)
JP (1) JPS6023114B2 (xx)
AT (1) AT365176B (xx)
AU (1) AU521524B2 (xx)
BE (1) BE873909A (xx)
CA (1) CA1102330A (xx)
CH (1) CH637122A5 (xx)
DE (1) DE2904445C2 (xx)
DK (1) DK159316C (xx)
ES (1) ES477457A1 (xx)
FI (1) FI66861C (xx)
FR (2) FR2421888A1 (xx)
GB (1) GB2013679B (xx)
GR (1) GR66846B (xx)
IE (1) IE47812B1 (xx)
IL (1) IL56578A (xx)
IT (1) IT1192347B (xx)
LU (1) LU80880A1 (xx)
NL (2) NL181482C (xx)
NO (1) NO151463C (xx)
NZ (1) NZ189553A (xx)
PT (1) PT69178A (xx)
SE (1) SE449360B (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466462A2 (fr) * 1978-02-06 1981-04-10 Synthelabo Derives d'alkylenediamines, leur preparation et leur application en therapeutique
EP0105838B1 (en) * 1982-09-30 1989-06-21 William John Louis 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
JPS6093016A (ja) * 1983-10-25 1985-05-24 Natl House Ind Co Ltd クランプ搬送装置
FR2577803B1 (fr) * 1985-02-26 1987-04-03 Synthelabo Compositions pharmaceutiques a base de nifedipine et d'alfuzosine
FR2577804B1 (fr) * 1985-02-26 1987-03-27 Synthelabo Compositions pharmaceutiques a base de verapamil et d'alfuzosine
FR2570275B1 (fr) * 1984-09-14 1986-11-21 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'alfusozine
EP0189336A1 (fr) * 1985-01-18 1986-07-30 Synthelabo Compositions pharmaceutiques contenant un alpha-bloquant et un antagoniste du calcium
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
LU86672A1 (fr) * 1986-11-19 1988-06-13 Oreal Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
NZ241979A (en) * 1991-03-20 1996-01-26 Merck & Co Inc Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US6313294B1 (en) 1998-02-04 2001-11-06 Development Center For Biotechnology Process for preparing amides
AU758802B2 (en) 1998-09-30 2003-03-27 Takeda Pharmaceutical Company Limited Drugs for improving vesical excretory strength
WO2001068615A1 (en) * 2000-03-13 2001-09-20 Chemrx Advanced Technologies, Inc. Quinazoline synthesis
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
JP2006511606A (ja) 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 下部尿路症状を治療するα−２−δリガンド
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
EP1789412B1 (en) * 2004-09-16 2008-05-07 Hetero Drugs Limited Crystalline alfuzosin base
DE602006003416D1 (de) * 2005-03-21 2008-12-11 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
CA2602383A1 (en) * 2005-03-21 2006-09-28 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
CA2618103A1 (en) * 2005-08-10 2007-02-15 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
US20070066824A1 (en) * 2005-09-22 2007-03-22 Anumula Raghupathi R Preparation of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
WO2007074364A1 (en) * 2005-12-26 2007-07-05 Aurobindo Pharma Limited Process for the preparation of alfuzosin
CN101190890B (zh) * 2006-11-30 2011-04-27 江苏豪森药业股份有限公司 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
US20080160081A1 (en) * 2006-12-11 2008-07-03 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making, and methods of use
WO2008152514A2 (en) 2007-05-04 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of alfuzosin and salts thereof
WO2009001369A1 (en) * 2007-06-22 2008-12-31 Alembic Limited An improved process for the preparation of alfuzosin hydrochloride
WO2009007987A1 (en) * 2007-07-11 2009-01-15 Alembic Limited An improved process for the preparation of alfuzosin and its novel polymorph
JP2010535185A (ja) * 2007-08-02 2010-11-18 シプラ・リミテッド アルフゾシン塩酸塩の製造方法
US20090076043A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched alfuzosin
US20100183717A1 (en) * 2009-01-16 2010-07-22 Kristin Arnold Controlled-release formulations
CN107998090A (zh) * 2017-12-30 2018-05-08 威海贯标信息科技有限公司 一种阿夫唑嗪片组合物
CN113801069B (zh) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 一种盐酸阿夫唑嗪中间体化合物
CN114573569B (zh) * 2022-03-30 2023-07-04 邦恩泰(山东)生物医药科技集团股份有限公司 一种异喹啉类化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
FR2362630A1 (fr) * 1976-08-24 1978-03-24 Synthelabo Derives d'alkylenediamines
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
FR2350101A1 (fr) * 1976-05-07 1977-12-02 Synthelabo Nouvelles guanidines cyclisees
FR2389613A2 (en) * 1977-05-05 1978-12-01 Synthelabo Antihypertensive 4-amino-6,7-di:methoxy-quinazolyl alkylene di:amine - prepd. from a 2-halo-quinazoline and an alkylene di:amine

Also Published As

Publication number Publication date
DE2904445C2 (de) 1986-10-30
BE873909A (fr) 1979-08-02
NO151463C (no) 1985-04-17
JPS6023114B2 (ja) 1985-06-05
NL930043I2 (nl) 1993-11-16
IL56578A0 (en) 1979-05-31
JPS54117487A (en) 1979-09-12
FI66861B (fi) 1984-08-31
PT69178A (fr) 1979-03-01
NL181482C (nl) 1987-09-01
GB2013679B (en) 1982-09-02
NZ189553A (en) 1981-05-01
DK159316B (da) 1990-10-01
FR2421888B1 (xx) 1980-09-26
ATA84279A (de) 1981-05-15
FI790369A (fi) 1979-08-07
NL930043I1 (nl) 1993-08-02
IT7919908A0 (it) 1979-02-05
AU4389579A (en) 1979-08-16
FR2421888A1 (fr) 1979-11-02
LU80880A1 (fr) 1980-09-24
DE2904445A1 (de) 1979-08-16
CH637122A5 (fr) 1983-07-15
FR2445323A2 (fr) 1980-07-25
IE790210L (en) 1979-08-06
CA1102330A (en) 1981-06-02
SE449360B (sv) 1987-04-27
IL56578A (en) 1983-02-23
NL7900917A (nl) 1979-08-08
IE47812B1 (en) 1984-06-27
DK46079A (da) 1979-08-07
NL181482B (nl) 1987-04-01
NO151463B (no) 1985-01-02
SE7900987L (sv) 1979-08-07
GR66846B (xx) 1981-05-05
DK159316C (da) 1991-03-04
IT1192347B (it) 1988-03-31
US4315007A (en) 1982-02-09
AT365176B (de) 1981-12-28
FR2445323B2 (xx) 1981-11-27
NO790358L (no) 1979-08-07
AU521524B2 (en) 1982-04-08
ES477457A1 (es) 1979-10-16
GB2013679A (en) 1979-08-15

Similar Documents

Publication Publication Date Title
FI66861C (fi) Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan
FI59990C (fi) Foerfarande foer framstaellning av pao centralnervsystemet verkande racemiska eller optiskt aktiva arylpiperaziner samt deras syraadditionssalter
US20050171357A1 (en) Process for preparing indolinone derivatives
JPS626703B2 (xx)
FR2644786A1 (fr) Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH09500883A (ja) α１Ａ−アドレナリン受容体アンタゴニストとしてのピペラジン誘導体
FR2655988A1 (fr) Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NO178968B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater
JPS6136260A (ja) 新規なイソインドリニル‐アルキル‐ピペラジン類およびその製法
US4341893A (en) Quinazoline derivatives
FI77456B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-/2-/4-(2-metoxifenyl) -1-piperazinyl/etyl/-2,4-(1h,3h)-kinazolindionderivat.
US3200151A (en) Arylaminoalkyl guanidines
HU182070B (en) Process for producing phenyl-piperazine derivatives
HUT70183A (en) Amidines derivated from 3-(amino-ethyl)-indoles, process for producing thereof and pharmaceutical compositions comprising them
FR2643373A1 (fr) Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
IE43222B1 (en) Piperazine derivatives
Balasubramanian et al. Synthesis of some spiroheterocycles
IE45423B1 (en) Process for hypotensive 2-(4-substituted piperazin-1-yl)-4-aminoquinazolines
FR2466462A2 (fr) Derives d'alkylenediamines, leur preparation et leur application en therapeutique
JPS6022714B2 (ja) キナゾリン誘導体及びその製造法
FI56530C (fi) Foerfarande foer framstaellning av 6-sulfamyl-1,2,3,4-tetrahydro-4-kinazolinoner
FI80678B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar ester av 1,4-dihydro-2,6-dimetyl-3-(alkoxi karbonyl eller elkoxialkoxikarbonyl)-4-substituerad fenyl)pyridin- 5-karboxylsyra.
US5322846A (en) 4-methylthiazole derivatives, their methods of preparation and the pharmaceutical compositions in which they are present
FI57403B (fi) Foerfarande foer framstaellning av blodtryckssaenkande 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
IL34741A (en) Basically substituted 2,4-(1h,3h)-quinazolinedione derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: SYNTHELABO